Institutional Ownership Catalyst Pharmaceuticals, Inc. (CPRX)
This table provides information about the institutional ownership of Catalyst Pharmaceuticals, Inc. (CPRX). We have compiled data on the 345 institutions that hold shares in the stock, with a total of 98.4 Million shares, which have been reported (via 13F filing form) to have a value of $2.17 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
18,694,918
shares
|
$404 Million
0.01% of portfolio
|
Q2 2024
Added 5.43%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
8,431,094
shares
|
$182 Million
0.0% of portfolio
|
Q4 2024
Added 4.85%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
5,796,560
shares
|
$125 Million
0.0% of portfolio
|
Q4 2024
Added 1.96%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Feb 14, 2025 Q4 2024 |
3,133,011
shares
|
$67.7 Million
1.62% of portfolio
|
Q4 2024
Reduced 49.71%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
3,013,032
shares
|
$65.1 Million
0.02% of portfolio
|
Q4 2024
Reduced 0.19%
|
|
|
Pacer Advisors, Inc.
Malvern, PA |
Jan 22, 2025 Q4 2024 |
2,955,508
shares
|
$63.9 Million
0.15% of portfolio
|
Q4 2024
Added 5.4%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
2,802,373
shares
|
$60.6 Million
0.01% of portfolio
|
Q4 2024
Added 90.35%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
2,706,116
shares
|
$58.5 Million
0.09% of portfolio
|
Q4 2024
Added 7.13%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
2,665,472
shares
|
$57.6 Million
0.0% of portfolio
|
Q4 2024
Added 0.04%
|
|
|
First Trust Advisors LP
Wheaton, IL |
Feb 13, 2025 Q4 2024 |
2,233,834
shares
|
$48.3 Million
0.04% of portfolio
|
Q4 2024
Reduced 8.03%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
2,088,050
shares
|
$45.1 Million
0.0% of portfolio
|
Q4 2024
Added 14.52%
|
|
|
Royce & Associates LP
|
Feb 10, 2025 Q4 2024 |
1,864,351
shares
|
$40.3 Million
0.38% of portfolio
|
Q4 2024
Reduced 7.76%
|
|
|
Castlekeep Investment Advisors LLC
Westport, CT |
Feb 14, 2025 Q4 2024 |
1,796,552
shares
|
$38.8 Million
0.38% of portfolio
|
Q4 2024
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
1,568,791
shares
|
$33.9 Million
0.0% of portfolio
|
Q4 2024
Added 139.53%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,503,566
shares
|
$32.5 Million
0.0% of portfolio
|
Q4 2024
Added 8.65%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,304,391
shares
|
$28.2 Million
0.01% of portfolio
|
Q4 2024
Added 14.51%
|
|
|
Boston Partners
Boston, MA |
Feb 10, 2025 Q4 2024 |
1,291,868
shares
|
$27.9 Million
0.03% of portfolio
|
Q4 2024
Added 1.3%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
1,246,925
shares
|
$27 Million
0.0% of portfolio
|
Q4 2024
Added 6.78%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
1,215,438
shares
|
$26.3 Million
0.0% of portfolio
|
Q4 2024
Reduced 1.53%
|
|
|
Kennedy Capital Management, Inc.
St Louis, MO |
Feb 13, 2025 Q4 2024 |
1,017,666
shares
|
$22 Million
0.5% of portfolio
|
Q4 2024
Reduced 2.28%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Feb 14, 2025 Q4 2024 |
912,999
shares
|
$19.7 Million
0.07% of portfolio
|
Q4 2024
Reduced 13.66%
|
|
|
Invesco Ltd.
Atlanta, GA |
Feb 13, 2025 Q4 2024 |
846,851
shares
|
$18.3 Million
0.0% of portfolio
|
Q4 2024
Reduced 9.86%
|
|
|
Lsv Asset Management
Chicago, IL |
Feb 13, 2025 Q4 2024 |
777,124
shares
|
$16.8 Million
0.04% of portfolio
|
Q4 2024
Reduced 18.31%
|
|
|
Mesirow Institutional Investment Management, Inc.
Chicago, IL |
Feb 13, 2025 Q4 2024 |
742,295
shares
|
$16 Million
1.22% of portfolio
|
Q4 2024
Reduced 7.31%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
736,197
shares
|
$15.9 Million
0.0% of portfolio
|
Q4 2024
Added 80.33%
|